文献速递临床试验与 GCP

内镜鼻窦手术改善成人复发性鼻窦炎生活质量的随机对照试验方案

Endoscopic sinus surgery (ESS) to change quality of life for adults with recurrent rhinosinusitis: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2021-09-08

本研究为单中心、非盲、随机、6个月平行组优效性临床试验,纳入80例转诊手术的成人复发性急性鼻窦炎(RARS)患者,比较内镜鼻窦手术(ESS)与保守药物治疗对疾病特异性生活质量问卷SNOT-22评分变化的影响,目前尚未有随机试验报道ESS对RARS的疗效。

要点

  • ESS可能通过改善鼻窦引流减轻RARS症状并提高生活质量。
  • 主要结局为SNOT-22评分从基线至6个月的变化组间差异。
  • 该试验将为ESS治疗成人RARS的获益与风险提供新证据。

核心结论

  • ESS对成人RARS患者生活质量的影响尚缺乏随机试验证据,本试验旨在填补该空白。

研究设计与样本

  • 单中心、非盲、随机、6个月平行组优效性临床试验,纳入80例因RARS转诊手术的成人参与者,随机接受ESS或保守药物治疗。

关键数值与推荐

  • 主要结局为ESS组与对照组SNOT-22评分从基线至6个月变化均值之间的差异。

局限性

  • 研究方案阶段,尚未报告实际结果;单中心、非盲设计可能引入偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endoscopic sinus surgery (ESS) has been used for decades to treat recurrent acute rhinosinusitis episodes (RARS) in adults. RARS results in infectious symptoms, antibiotic courses, sick leaves, and impaired quality of life. Theoretically, the ESS procedure, through improving the drainage of the paranasal sinuses, decreases the symptoms and enhances the quality of life of the RARS patients. Whether this is true has not been reported in a randomized trial yet. METHODS: We conduct a single-center, non-blinded, randomized, 6-month, parallel group superiority clinical study including 80 adult participants referred to surgical treatment for RARS. The participants will either have ESS or conservative medical treatment (control group). The primary outcome will be the difference between the mean disease-specific Sinonasal Outcome Test 22 (quality of life questionnaire) change scores (from baseline to 6 months) of ESS and control group. DISCUSSION: This study will add significant new information to the effect and harms of ESS procedure in the treatment of adults with RARS. TRIAL REGISTRATION: ClinicalTrials.gov NCT04241016 . Registered on 17 January 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Kaski HM, Alakärppä A, Lantto U, et al. Endoscopic sinus surgery (ESS) to change quality of life for adults with recurrent rhinosinusitis: study protocol for a randomized controlled trial. Trials. 2021. PMID: 34496924. doi:10.1186/s13063-021-05576-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。